We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-15.35%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.86B
AUM Growth
-$316M
Cap. Flow
+$201M
Cap. Flow %
10.84%
Top 10 Hldgs %
33.97%
Holding
201
New
20
Increased
89
Reduced
75
Closed
17

Top Buys

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$28.3M
2
AXON
Axon Enterprise
AXON
+$25.9M
3
BFAM icon
Bright Horizons
BFAM
+$22.8M
4
LPSN icon
LivePerson
LPSN
+$22.6M
5
MGNI icon
Magnite
MGNI
+$20.2M

Top Sells

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$24M
2
ENPH icon
Enphase Energy
ENPH
+$23.5M
3
MDCO
Medicines Co
MDCO
+$23.4M
4
EHTH icon
eHealth
EHTH
+$22.6M
5
TDOC icon
Teladoc Health
TDOC
+$18.9M

Sector Composition

Rank Sector Weight
1 Technology 35.7%
2 Healthcare 18.21%
3 Industrials 12.95%
4 Consumer Staples 7.14%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETTX
176
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$409K 0.02%
154,658
-2,286
-1% -$10.3K
RNG icon
177
RingCentral
RNG
$5.3B
$380K 0.02%
1,792
+212
+13% +$43.7K
PODD icon
178
Insulet
PODD
$10B
$340K 0.02%
2,050
-1,449
-41% -$265K
OTIC
179
DELISTED
Otonomy, Inc.
OTIC
$326K 0.02%
+165,482
New +$510K
RDNW
180
RideNow Group
RDNW
$251M
$303K 0.02%
72,514
-31,363
-30% -$293K
AGX icon
181
Argan
AGX
$8.11B
$270K 0.01%
+7,797
New +$323K
TACT icon
182
Transact Technologies
TACT
$59.4M
$252K 0.01%
81,094
+39,695
+96% +$363K
TTOO
183
DELISTED
T2 Biosystems, Inc
TTOO
$202K 0.01%
62
-2
-3% -$8.31K
NBRV
184
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$149K 0.01%
1,036
-30
-3% -$9.18K
AIN icon
185
Albany International
AIN
$1.79B
– –
-95,230
Closed -$7.23M
ANGI icon
186
Angi Inc
ANGI
$182M
– –
-2,446
Closed -$207K
CLAR icon
187
Clarus
CLAR
$146M
– –
-128,003
Closed -$1.73M
HDSN
188
Hudson Technologies
HDSN
$233M
– –
-174,339
Closed -$170K
IONS icon
189
Ionis Pharmaceuticals
IONS
$9.21B
– –
-3,536
Closed -$214K
LYV icon
190
Live Nation Entertainment
LYV
$42.7B
– –
-4,475
Closed -$320K
MMSI icon
191
Merit Medical Systems
MMSI
$5.44B
– –
-17,850
Closed -$557K
PNTG icon
192
Pennant Group
PNTG
$1.33B
– –
-186,171
Closed -$6.16M
PUMP icon
193
ProPetro Holding
PUMP
$1.43B
– –
-401,634
Closed -$4.52M
MIXT
194
DELISTED
MIX TELEMATICS LIMITED
MIXT
– –
-21,617
Closed -$280K
TRTN
195
DELISTED
Triton International Limited
TRTN
– –
-8,559
Closed -$344K
IVC
196
DELISTED
Invacare Corporation
IVC
– –
-552,405
Closed -$4.98M
RP
197
DELISTED
RealPage, Inc.
RP
– –
-7,185
Closed -$386K
ZAGG
198
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
– –
-41,965
Closed -$340K
WAAS
199
DELISTED
AquaVenture Holdings Limited
WAAS
– –
-171,570
Closed -$4.65M
MLNT
200
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
– –
-241,853
Closed -$128K
5 6 7
8
9

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q1 2020 Portfolio in Review

As of Q1 2020, Granahan Investment Management held 201 positions worth $1.86B, down 15% from $2.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Granahan Investment Management deployed $201M of net new capital in Q1 2020, opening 20 new positions and adding to 89 existing holdings. Its largest new stake was Trade Desk: 1,094,660 shares worth $21.1M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was CoStar Group, an estimated $24M trimmed.

  • Granahan Investment Management's largest Q1 2020 buy was Trade Desk: 1,094,660 shares worth $21.1M.
  • Granahan Investment Management added most to Axon Enterprise in Q1 2020, an estimated $25.9M increase.
  • Granahan Investment Management's biggest Q1 2020 reduction was CoStar Group, cutting an estimated $24M.
  • Granahan Investment Management fully exited Medicines Co in Q1 2020, selling an estimated $23.4M.
  • Granahan Investment Management's ten largest holdings make up 34% of its $1.86B portfolio in Q1 2020.
  • Granahan Investment Management opened 20 new positions and closed 17 in Q1 2020.
  • Granahan Investment Management's portfolio value fell 15% quarter-over-quarter to $1.86B.

Based on Granahan Investment Management's 13F filing for Q1 2020, filed 12 May 2020.